← Return to Ultrasensitive PSA Test Post RP
DiscussionUltrasensitive PSA Test Post RP
Prostate Cancer | Last Active: Jan 10, 2023 | Replies (40)Comment receiving replies
Replies to "We were told .2 (with confirming timely retesting) means reoccurance and it is not wise to..."
What you say is definitely a good way to look at it and decide.
It does make sense to hit it early...as I said, only makes sense to wait if imaging will change the treatment plan.
If the decision is SRT to the prostate bed only, that I would hesitate doing based on Mayo's own data.
It was a decision I let my medical team make when I had BCR, ignoring the data emerging from clinical trials
When that failed and I had to do ADT, chemotherapy and radiation, well, mono therapy was a word that I deleted from my decision making. That and I added shared decision making.